2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Glenn N. Levine, Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn, Lee A. Fleisher, Christopher B. Granger, Richard A. Lange, Michael J. Mack, Laura Mauri, Roxana Mehran, Debabrata Mukherjee, L. Kristin Newby, Patrick T. O'Gara, Marc S. Sabatine, Peter K. Smith, Sidney C. Smith

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1082-1115
Number of pages34
JournalJournal of the American College of Cardiology
Volume68
Issue number10
DOIs
StatePublished - Sep 6 2016

Keywords

  • ACC/AHA Clinical Practice Guideline
  • P2Y inhibitor
  • acute coronary syndrome
  • aspirin
  • coronary artery disease
  • coronary stents
  • dual antiplatelet therapy (DAPT)
  • focused update
  • stable ischemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., Mehran, R., Mukherjee, D., Newby, L. K., O'Gara, P. T., Sabatine, M. S., Smith, P. K., & Smith, S. C. (2016). 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 68(10), 1082-1115. https://doi.org/10.1016/j.jacc.2016.03.513